Minimally invasive surgery for rectal cancer is now
widely performed via the laparoscopic approach and
has been validated in randomized controlled trials to be
oncologically safe with better perioperative outcomes
than open surgery including shorter length of stay,
earlier return of bowel function, better cosmesis,
and less analgesic requirement